Lesson plan

Flufenoxine

Flufenoxine (F-98214-TA) is a Serotonin–norepinephrine reuptake inhibitor. It can be used to treat disorders of the central nervous system, particularly depression and anxiety. It was developed by a Spanish company at the beginning of the 21st century. Flufenoxine derivatives have been patented for the treatment of Alzheimer's disease. Analogues of Flufenoxine were reported containing a duloxetine-type thiophene surrogate ring moiety. Such agents possess the desired triple-mode of activity (serotonin-noradrenaline and dopamine) (cf. SNDRI). For another related SNDRI agent see PC71812205. The racemic agent had IC50's of 11, 14, 190nM S~N>D.

Back to article

Article summary

Flufenoxine (F-98214-TA) is a Serotonin–norepinephrine reuptake inhibitor. It can be used to treat disorders of the central nervous system, particularly depression and anxiety. It was developed by a Spanish company at the beginning of the 21st century. Flufenoxine derivatives have been patented for the treatment of Alzheimer's disease. Analogues of Flufenoxine were reported containing a duloxetine-type thiophene surrogate ring moiety. Such agents possess the desired triple-mode of activity (serotonin-noradrenaline and dopamine) (cf. SNDRI). For another related SNDRI agent see PC71812205. The racemic agent had IC50's of 11, 14, 190nM S~N>D.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.